Power Law company profile

Apogee Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2022 · IPO 2023 Unicorn

Develops advanced biologics for treating inflammatory and immune diseases like atopic dermatitis and asthma

Valuation

$5.53B

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

9 investors on Apogee Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Fairmount Funds Management

Venrock Healthcare Capital Partners

Series B+ 7 investors entered at this stage

RA Capital Management

OrbiMed

Fidelity Investments

Deep Track Capital

Wellington Management

Perceptive Xontogeny Venture Fund

RTW Investments

Global footprint

Where Apogee Therapeutics has talent and traffic

Workforce by country

4 countries with
team presence

🇺🇸 United States97.5%

🇨🇦 Canada1.4%

🇩🇪 Germany0.8%

🇩🇰 Denmark0.5%

4 countries shown

Web traffic by country

70K monthly visits
across markets

🇪🇸 Spain57.6%

🇺🇸 United States34.4%

🇬🇧 United Kingdom1.9%

🇨🇦 Canada1.4%

🇩🇪 Germany1%

Top 5 markets shown

Patent intelligence

$184k patent portfolio · 5 active families

Estimated portfolio value

$184k

<0.01% of market cap · 1779.6× smaller than top peer Genmab ($328M)

5 active patent families

Where Apogee Therapeutics innovates Antiendomysial antibodiesMolecular biologyBiological activityAnti antibodyDrug biological activity

Where Apogee Therapeutics concentrates vs peers

Each axis is a top-10 topic across Apogee Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Apogee Therapeutics

An AI-synthesized read of the highest-engagement posts about Apogee Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Apogee Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles